When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BPMC - Blueprint Hits Study Goal With Main Drug Avapritinib Additional Studies Being Advanced
Blueprint Medicines Corporation
Blueprint Medicines (BPMC) announced that it had achieved positive results from a phase 2 study using its cancer drug avapritinib treating patients with indolent systemic mastocytosis (SM). Not only did this drug achieve the clinical endpoints, but it is able to move on to part 2 of the study. That's because now it has the best recommended dose to move forward with and prove that the drug works for this rare disease population. Avapritinib is also going to be advanced for advanced systemic mastocytosis (ASM). This will provide another opportunity in the same